Home › Funds › Villanova Investment Management Co LLC › SUPN
Villanova Investment Management Co LLC position in SUPN
SUPERNUS PHARMACEUTICALS · Health Care
Villanova Investment Management Co LLC reported holding 34,934 shares of SUPN (SUPERNUS PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$1.5M, representing 1.50% of its reported portfolio and ranking #34 among its reported holdings. Villanova Investment Management Co LLC has disclosed SUPN holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-02 · Source: SEC EDGAR Form 13F-HR
How Villanova Investment Management Co LLC's SUPN position evolved
Villanova Investment Management Co LLC first disclosed a stake in SUPN in Q2 2024 at 51,478 shares (US$1.4M). The position peaked in Q3 2025 at 54,868 shares, worth US$2.6M. Across 10 filings, Villanova Investment Management Co LLC increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 34,934 shares valued at US$1.5M. Notable position changes include a 66% trim in Q1 2025 (shares fell 4% over the following quarter), a 167% increase in Q2 2025 (shares rose 52% over the following quarter), a 27% trim in Q1 2026 (shares fell 10% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 51.48K | $1.38M | New |
| Q3 2024 | 51.54K | $1.61M | Hold |
| Q4 2024 | 57.03K | $2.06M | Add |
| Q1 2025 | 19.59K | $1.87M | Reduce |
| Q2 2025 | 52.32K | $1.65M | Add |
| Q3 2025 | 54.87K | $2.62M | Add |
| Q4 2025 | 48.05K | $2.39M | Reduce |
| Q1 2026 | 34.93K | $1.81M | Reduce |
| Q2 2026 | 34.93K | $1.62M | Hold |
| Q3 2026 | 34.93K | $1.50M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SUPN and 13F data
SUPN (SUPERNUS PHARMACEUTICALS) is a Health Care company. 35 other funds we track also report a position in SUPN — the largest reported positions include MILLENNIUM MANAGEMENT LLC (US$179.2M), ARMISTICE CAPITAL, LLC (US$123.1M), Sofinnova Investments, Inc. (US$48.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SUPN
- MILLENNIUM MANAGEMENT LLC 3.85M sh · $179.21M · Q2 2026
- ARMISTICE CAPITAL, LLC 2.65M sh · $123.07M · Q2 2026
- Sofinnova Investments, Inc. 1.04M sh · $48.20M · Q2 2026
- ASHFORD CAPITAL MANAGEMENT INC 613.78K sh · $28.55M · Q2 2026
- Soleus Capital Management, L.P. 520.00K sh · $24.19M · Q2 2026
- RICE HALL JAMES & ASSOCIATES, LLC 490.22K sh · $22.80M · Q2 2026
More on Villanova Investment Management Co LLC
FAQ
How long has Villanova Investment Management Co LLC held SUPN?
Villanova Investment Management Co LLC has disclosed SUPN holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is Villanova Investment Management Co LLC's current position in SUPN?
As of Q3 2026, Villanova Investment Management Co LLC holds 34.93K shares of SUPN (SUPERNUS PHARMACEUTICALS), valued at $1.50M, representing 1.50% of its reported portfolio and ranking #34.
Has Villanova Investment Management Co LLC been buying or selling SUPN?
In the latest 13F filing (Q3 2026), Villanova Investment Management Co LLC held unchanged its position in SUPN. The position peaked in Q3 2025 at 54.87K shares.
Which other funds hold SUPN?
Other major institutional holders of SUPN include MILLENNIUM MANAGEMENT LLC, ARMISTICE CAPITAL, LLC, Sofinnova Investments, Inc., among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.